MATHEW PATHROSE: Open Payments
NPI 1710258496 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,260 in 25 payments from 13 companies in 2025. Trend: 2023 $3,959 · 2024 $1,265 · 2025 $1,260
Food & beverage: $1,161Education: $99
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $289 |
| Galderma Laboratories, L.P. | 3 | $176 |
| LEO Pharma Inc. | 1 | $136 |
| PFIZER INC. | 1 | $125 |
| UCB, Inc. | 4 | $113 |
| Arcutis Biotherapeutics, Inc. | 1 | $107 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| GENZYME CORPORATION | 2 | $57 |
| Incyte Corporation | 2 | $51 |
| Organon LLC | 3 | $39 |
Products named: NEMLUVIO, ANZUPGO, KRYSTEXXA, LITFULO, DUPIXENT, Bimzelx, Zoryve, OPZELURA.
Industry payments across NY — which companies pay providers there.
